Hussman Strategic Advisors, Inc. Adma Biologics, Inc. Transaction History

Hussman Strategic Advisors, Inc.

  • $386 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021
SELL
$1.67 - $2.95 $136,940 - $241,900
-82,000 Closed
0 $0
Q4 2020

Feb 01, 2021
SELL
$1.8 - $2.56 $32,400 - $46,080
-18,000 Reduced 18.0%
82,000 $160,000
Q3 2020

Nov 02, 2020
BUY
$2.04 - $3.74 $204,000 - $374,000
100,000 New
100,000 $239,000

Others Institutions Holding ADMA

# of Institutions
317
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.27B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email